CymitQuimica logo

CAS 128298-28-2

:

Remacemide

Description:
Remacemide is a chemical compound primarily studied for its potential use in the treatment of neurological disorders, particularly epilepsy and Alzheimer's disease. It is classified as an anticonvulsant and is known to act as a glutamate receptor antagonist, which helps modulate excitatory neurotransmission in the brain. The molecular structure of Remacemide includes a piperidine ring, contributing to its pharmacological properties. It is typically administered in its hydrochloride salt form, enhancing its solubility and bioavailability. Remacemide has been investigated for its ability to reduce seizure frequency and improve cognitive function, although its clinical use has been limited. The compound is characterized by its moderate lipophilicity, which influences its distribution in biological systems. Safety and efficacy profiles are essential considerations in its development, and ongoing research continues to explore its mechanisms of action and potential therapeutic applications. As with any pharmaceutical agent, understanding its pharmacokinetics and pharmacodynamics is crucial for optimizing its use in clinical settings.
Formula:C17H20N2O
InChI:InChI=1S/C17H20N2O/c1-17(19-16(20)13-18,15-10-6-3-7-11-15)12-14-8-4-2-5-9-14/h2-11H,12-13,18H2,1H3,(H,19,20)
InChI key:InChIKey=YSGASDXSLKIKOD-UHFFFAOYSA-N
SMILES:C(CC1=CC=CC=C1)(NC(CN)=O)(C)C2=CC=CC=C2
Synonyms:
  • (+/-)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide
  • (±)-Remacemide
  • 2-Amino-N-(1,2-diphenyl-1-methylethyl)acetamide
  • 2-Amino-N-(1,2-diphenylpropan-2-yl)acetamide
  • Acetamide, 2-amino-N-(1-methyl-1,2-diphenylethyl)-
  • Ar-R 12924
  • Fpl 12924
  • N-(1,2-diphenylpropan-2-yl)glycinamide
  • Pr 934-423
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.